Rempex Company Profile
✉ Email this page to a colleague
What is the competitive landscape for REMPEX, and what generic alternatives to REMPEX drugs are available?
REMPEX has two approved drugs.
There are nine US patents protecting REMPEX drugs.
There are eighty-nine patent family members on REMPEX drugs in thirty-two countries and thirty supplementary protection certificates in fourteen countries.
Summary for Rempex
| International Patents: | 89 |
| US Patents: | 9 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Rempex
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rempex | VABOMERE | meropenem; vaborbactam | POWDER;INTRAVENOUS | 209776-001 | Aug 29, 2017 | RX | Yes | Yes | 8,680,136 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
| Rempex | VABOMERE | meropenem; vaborbactam | POWDER;INTRAVENOUS | 209776-001 | Aug 29, 2017 | RX | Yes | Yes | 10,561,675 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Rempex | VABOMERE | meropenem; vaborbactam | POWDER;INTRAVENOUS | 209776-001 | Aug 29, 2017 | RX | Yes | Yes | 11,007,206 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Rempex | MINOCIN | minocycline hydrochloride | INJECTABLE;INJECTION | 050444-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | 9,278,105 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Rempex | VABOMERE | meropenem; vaborbactam | POWDER;INTRAVENOUS | 209776-001 | Aug 29, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Rempex Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Turkey | 201815323 | ⤷ Try a Trial |
| Colombia | 6650346 | ⤷ Try a Trial |
| Russian Federation | 2012147527 | ⤷ Try a Trial |
| Hungary | E048859 | ⤷ Try a Trial |
| Israel | 222896 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Rempex Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 3412676 | C20200018 00316 | Estonia | ⤷ Try a Trial | PRODUCT NAME: VABORBAKTAAM;REG NO/DATE: EU/1/18/1334 22.11.2018 |
| 2603514 | C02603514/02 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: VABORBACTAM UND MEROPENEM; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 67797 01.07.2021 |
| 2603514 | 132019000000049 | Italy | ⤷ Try a Trial | PRODUCT NAME: VABORBACTAM E/O UN SUO SALE E/O UN SUO IDRATO(VABOMERE); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/18/1334, 20181122 |
| 2603514 | CA 2019 00015 | Denmark | ⤷ Try a Trial | PRODUCT NAME: EN KOMBINATION AF VABORBACTAM, OG/ELLER ET SALT OG/ELLER HYDRAT DERAF, OG MEROPENEM, OG/ELLER ET SALT OG/ELLER HYDRAT DERAF, SAERLIGT MEROPENEM TRIHYDRAT; REG. NO/DATE: EU/1/18/1334 20181122 |
| 2603514 | C02603514/01 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: VABORBACTAM; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 67797 01.07.2021 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
